Viagra

Playboy Enterprises, which launched in 1963 as a magazine business, is now more of a brand business given the downturn of print magazines. The company could be hitting public markets again via a special purpose acquisition company. What Happened: The New York Post reported Tuesday that Playboy...

Previewing second-quarter results of Pfizer Inc. (NYSE: PFE), Credit Suisse prescribed a Neutral rating for the shares of the company, down from its previous Outperform rating. Pfizer is scheduled to release its second-quarter results at 7 a.m. ET on Aug. 1. Analysts led by Vamil Divan expect...

The U.S. Food and Drug Administration has issued a series of warnings about a handful of over-the-counter male sexual enhancement supplements. According to the FDA, laboratory analysis has identified that the following supplements contain a drug that could be life-threatening to certain users:...

Among the earnings highlights for the week will be the reports from two major pharmaceutical companies. Wall Street analysts are looking for earnings growth from only one of them. Both companies have exceeded earnings estimates in recent quarters. The earnings season rolls on even as...

Pfizer (NYSE: PFE) reported second quarter earnings that beat analyst estimates. However, with the loss of Lipitor exclusivity and Viagra next to go, the future remains challenging. Pfizer's net income increased in the quarter, jumping 25 percent to $3.25 billion from $2.61 billion a year ago....